Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset

Susanne M Cabrera, Xujing Wang, Yi-Guang Chen, Shuang Jia, Mary L Kaldunski, Carla J Greenbaum, Thomas Mandrup-Poulsen, Martin J Hessner

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Neuroscience

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science